303 related articles for article (PubMed ID: 35806075)
1. Molecular Basis Underlying the Therapeutic Potential of Vitamin D for the Treatment of Depression and Anxiety.
Kouba BR; Camargo A; Gil-Mohapel J; Rodrigues ALS
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806075
[TBL] [Abstract][Full Text] [Related]
2. Potential Role of Vitamin D for the Management of Depression and Anxiety.
Casseb GAS; Kaster MP; Rodrigues ALS
CNS Drugs; 2019 Jul; 33(7):619-637. PubMed ID: 31093951
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D is a potential antidepressant in psychiatric outpatients
.
Abdul-Razzak KK; Almanasrah SO; Obeidat BA; Khasawneh AG
Int J Clin Pharmacol Ther; 2018 Dec; 56(12):585-596. PubMed ID: 30336806
[TBL] [Abstract][Full Text] [Related]
4. Putative Antidepressant Effect of Chamomile (
Amsterdam JD; Li QS; Xie SX; Mao JJ
J Altern Complement Med; 2020 Sep; 26(9):813-819. PubMed ID: 31808709
[No Abstract] [Full Text] [Related]
5. Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.
Glue P; Medlicott NJ; Harland S; Neehoff S; Anderson-Fahey B; Le Nedelec M; Gray A; McNaughton N
J Psychopharmacol; 2017 Oct; 31(10):1302-1305. PubMed ID: 28441895
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of B-vitamins and vitamin D therapy in improving depressive and anxiety disorders: a systematic review of randomized controlled trials.
Borges-Vieira JG; Cardoso CKS
Nutr Neurosci; 2023 Mar; 26(3):187-207. PubMed ID: 35156551
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D supplementation ameliorates severity of generalized anxiety disorder (GAD).
Eid A; Khoja S; AlGhamdi S; Alsufiani H; Alzeben F; Alhejaili N; Tayeb HO; Tarazi FI
Metab Brain Dis; 2019 Dec; 34(6):1781-1786. PubMed ID: 31478182
[TBL] [Abstract][Full Text] [Related]
8. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.
Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS
Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological characterization and mechanisms of the novel antidepressive- and/or anxiolytic-like substances identified from Perillae Herba].
Tsuji M; Miyagawa K; Takeuchi T; Takeda H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):159-67. PubMed ID: 18800619
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D supplements in geriatric major depression.
Zanetidou S; Belvederi Murri M; Buffa A; Malavolta N; Anzivino F; Bertakis K
Int J Geriatr Psychiatry; 2011 Nov; 26(11):1209-10. PubMed ID: 23658119
[No Abstract] [Full Text] [Related]
11. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
[TBL] [Abstract][Full Text] [Related]
12. The Role of Water-Soluble Vitamins and Vitamin D in Prevention and Treatment of Depression and Seasonal Affective Disorder in Adults.
Jahan-Mihan A; Stevens P; Medero-Alfonso S; Brace G; Overby LK; Berg K; Labyak C
Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931257
[TBL] [Abstract][Full Text] [Related]
13. [Current treatment of depression and agitation in the elderly -- clinical use of trazodone].
Osváth P
Neuropsychopharmacol Hung; 2013 Sep; 15(3):147-55. PubMed ID: 24108179
[TBL] [Abstract][Full Text] [Related]
14. Vitamins C and D Exhibit Similar Antidepressant Effects to Escitalopram Mediated by NOx and FKBPL in a Stress-Induced Mice Model.
Gammoh O; Ibrahim A; Qnais E; Alqudah A; Altaber S; Aljabali AAA; Tambuwala MM
Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375593
[TBL] [Abstract][Full Text] [Related]
15. SuHeXiang Essential Oil Inhalation Produces Antidepressant- and Anxiolytic-Like Effects in Adult Mice.
Liang M; Du Y; Li W; Yin X; Yang N; Qie A; Lebaron TW; Zhang J; Chen H; Shi H
Biol Pharm Bull; 2018 Jul; 41(7):1040-1048. PubMed ID: 29743387
[TBL] [Abstract][Full Text] [Related]
16. Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users.
Bot M; Milaneschi Y; Penninx BW; Drent ML
Psychoneuroendocrinology; 2016 Jun; 68():148-55. PubMed ID: 26974499
[TBL] [Abstract][Full Text] [Related]
17. The Discriminative Stimulus Properties of Drugs Used to Treat Depression and Anxiety.
Prus AJ; Porter JH
Curr Top Behav Neurosci; 2018; 39():213-241. PubMed ID: 27352389
[TBL] [Abstract][Full Text] [Related]
18. The Role of Dietary Supplements in Depression and Anxiety - A Narrative Review.
Hoffmann K; Emons B; Brunnhuber S; Karaca S; Juckel G
Pharmacopsychiatry; 2019 Nov; 52(6):261-279. PubMed ID: 31284313
[TBL] [Abstract][Full Text] [Related]
19. Metformin Promotes Anxiolytic and Antidepressant-Like Responses in Insulin-Resistant Mice by Decreasing Circulating Branched-Chain Amino Acids.
Zemdegs J; Martin H; Pintana H; Bullich S; Manta S; Marqués MA; Moro C; Layé S; Ducrocq F; Chattipakorn N; Chattipakorn SC; Rampon C; Pénicaud L; Fioramonti X; Guiard BP
J Neurosci; 2019 Jul; 39(30):5935-5948. PubMed ID: 31160539
[TBL] [Abstract][Full Text] [Related]
20. Acute reduction in anxiety after deep transcranial magnetic stimulation (DTMS) in unipolar major depression- a systematic review and meta-analysis.
Kedzior KK; Gellersen HM; Roth Y; Zangen A
Psychiatry Res; 2015 Dec; 230(3):971-4. PubMed ID: 26616303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]